Singapore-listed medical supplies group QT Vascular has reached a settlement with rival specialty balloon angioplasty firm AngioScore.
They have been involved in a lengthy, expensive and damaging series of patent related court cases claiming breach of fiduciary duty, aiding and abetting the breach and unfair competition for several years.
On 14 November, QT Vascular reached a confidential settlement agreement with AngioScore. The effect of the settlement agreement is to resolve all past, present or future disputes concerning the subject matter of the pending or previously litigated matters between the group and AngioScore fully and finally.